Printer Friendly

Pulmonary Fibrosis Foundation Acquires Daughters of Pulmonary Fibrosis Programme.


20 November 2015 - US-based non-profit The Pulmonary Fibrosis Foundation has acquired all rights to the Daughters of Pulmonary Fibrosis programme from the Coalition for Pulmonary Fibrosis, a California-based 501c3 nonprofit public benefit organisation serving the pulmonary fibrosis community, The PFF said.

The foundation has assumed administration of the Daughters of PF programme and funds raised through this effort will go toward serving the PF patient community and advocating for caregiver needs.

This programme was founded by the CPF to expand awareness of pulmonary fibrosis via grassroots events and fundraisers across the nation and generate a broader understanding of the impact the disease has on those living with PF and their families.

With support from the Pulmonary Fibrosis Foundation, volunteers for the Daughters of PF programme will continue its work as part of the PFF's signature programs, which includes other volunteer programs with national reach, such as the PFF Ambassador program and the PFF Support Group Leader Network.

Idiopathic pulmonary fibrosis is a condition in which, over a period of time, lung tissue becomes thickened, stiff and scarred. The development of the scar tissue is called fibrosis.

As the lung tissue becomes scarred and grows thicker, the lungs lose their ability to transfer oxygen into the bloodstream. As a result, the brain and other organs don't receive enough oxygen. In some cases, doctors can determine the cause of the fibrosis, but in many cases, there is no known cause.

When the cause of the fibrosis is unknown (and certain pathologic or radiographic criteria are met), the disease is called idiopathic pulmonary fibrosis or IPF. There is no cure for IPF. Presently, there are two FDA-approved treatments for IPF in the US.

The mission of the Pulmonary Fibrosis Foundation is to serve as the resource for the pulmonary fibrosis community by raising awareness, providing disease education, advancing care and funding research.

This groupcollaborates with physicians, organisations, people with PF and caregivers worldwide. The Pulmonary Fibrosis Foundation has a four-star rating from Charity Navigator and is a Better Business Bureau accredited charity.

Country: USA

Sector: Healthcare

Target: Rights to the Daughters of Pulmonary Fibrosis programme

Buyer: The Pulmonary Fibrosis Foundation

Vendor: Coalition for Pulmonary Fibrosis

Deal size in USD:

Type: Corporate Acquisition


Status: Closed

Buyer advisor: , ,

Comment: Terms of the deal were not disclosed

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Nov 20, 2015
Previous Article:Microsemi: PMC-Sierra Deem Revised Proposal Superior to Skyworks Bid.
Next Article:Cologix Completes Closes New Jersey Data Centre Acquisition.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters